IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $347,000 | +122.4% | 72,610 | +121.4% | 0.01% | +140.0% |
| Q1 2022 | $156,000 | +2500.0% | 32,798 | +3959.2% | 0.01% | – |
| Q4 2021 | $6,000 | -62.5% | 808 | -67.3% | 0.00% | -100.0% |
| Q4 2020 | $16,000 | – | 2,469 | +2320.6% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 102 | -98.7% | 0.00% | -100.0% |
| Q2 2019 | $18,000 | +1700.0% | 8,077 | +3006.5% | 0.01% | – |
| Q1 2019 | $1,000 | -88.9% | 260 | -86.1% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | 0.0% | 1,870 | +118.2% | 0.00% | -20.0% |
| Q1 2018 | $9,000 | +125.0% | 857 | +51.7% | 0.01% | +66.7% |
| Q4 2017 | $4,000 | -82.6% | 565 | -94.9% | 0.00% | -87.0% |
| Q4 2016 | $23,000 | – | 11,161 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |